HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jenkinson, S. R. Articles by Morgan, D. J. Search for Related Content PubMed PubMed Citation Articles by Jenkinson, S. R. Articles by Morgan, D. J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH

The Role of Intercellular Adhesion Molecule-1/LFA-1 Interactions in the Generation of Tumor-Specific CD8⁺ T Cell Responses¹

Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, Bristol, United Kingdom

The activation of naive CD4⁺ T cells requires both TCR engagement and a second costimulatory signal mediated by the interaction of CD28 with CD80/CD86 expressed on professional APC. However, the situation for naive CD8⁺ T cells is less clear. Although evidence indicates that induction of CD8⁺ T cell responses is also dependent on professional APC, the ability of some tumors, which do not express CD80/CD86, to induce CTL suggests that other pathways of costimulation exist for the activation of CD8⁺ T cells. We examined the ability of tumor cells expressing different levels of a tumor-specific Ag to directly prime CD8⁺ T cells. We demonstrate that CD8⁺ T cells are directly activated by tumor cells in a CD80/CD86-CD28 independent manner. In this system, costimulation requires ICAM-1/LFA-1 interaction. This results in the generation of CTL capable of inhibiting tumor growth in vivo, and maintaining long-term survival.

This article has been cited by other articles:

				M. Ahmadi, D. C. Emery, and D. J. Morgan Prevention of Both Direct and Cross-Priming of Antitumor CD8+ T-Cell Responses following Overproduction of Prostaglandin E2 by Tumor Cells In vivo Cancer Res., September 15, 2008; 68(18): 7520 - 7529. [Abstract] [Full Text] [PDF]

				C. N. Janicki, S. R. Jenkinson, N. A. Williams, and D. J. Morgan Loss of CTL Function among High-Avidity Tumor-Specific CD8+ T Cells following Tumor Infiltration Cancer Res., April 15, 2008; 68(8): 2993 - 3000. [Abstract] [Full Text] [PDF]

				R. Castriconi, A. Dondero, C. Cantoni, M. Della Chiesa, C. Prato, M. Nanni, M. Fiorini, L. Notarangelo, S. Parolini, L. Moretta, et al. Functional characterization of natural killer cells in type I leukocyte adhesion deficiency Blood, June 1, 2007; 109(11): 4873 - 4881. [Abstract] [Full Text] [PDF]

				S. A. Wuensch, R. H. Pierce, and I. N. Crispe Local Intrahepatic CD8+ T Cell Activation by a Non-Self- Antigen Results in Full Functional Differentiation J. Immunol., August 1, 2006; 177(3): 1689 - 1697. [Abstract] [Full Text] [PDF]